National Hog Farmer is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BIVI launches SOURCE for PED management information

To provide pork producers and veterinarians the practical management protocols and a comprehensive information resource to help them achieve more effective prevention and control of porcine epidemic diarrhea virus, Boehringer Ingelheim Vetmedica Inc., introduces SOURCE.

According to Greg Cline, DVM, technical manager for enteric disease products at BIVI, SOURCE is a six-step systematic approach to PED prevention and control featuring one of the industry’s most complete information resources on PED. It was developed based on the company’s decades of experience and extensive research with other highly infectious swine diseases.

SOURCE is an acronym, with each letter representing one of six steps in the protocol: State desired goals; Obtain current status; Understand current risk factors; Reduce risk factors; Construct solutions; and Execute and monitor solutions.

Each step of SOURCE helps producers to objectively evaluate all components of their production systems, assess various risk factors and, based on that information, develop and execute proper management solutions that best fit their farm goals.

SOURCE also is a consolidated information resource that utilizes BIVI’s swine technical and diagnostic expertise. The site includes links to additional university and industry sites and an interactive risk analysis and herd management plan. Because the site is an always-evolving information platform, any new PED data and information will be shared as it becomes available. The company has plans to expand SOURCE later this year to include expanded risk analysis and links to additional resources.

Information on PED SOURCE can be found at For more information on Boehringer Ingelheim Vetmedica Inc., visit